Use of CD25 binding molecules in the treatment of inflammatory diseases of the gastro-intestinal tract

Details for Australian Patent Application No. 2001246516 (hide)

Owner Novartis AG

Inventors Farber, Lothar; Adam, Hansjoerg

Agent Davies Collison Cave

Pub. Number AU-B-2001246516

PCT Pub. Number WO01/72845

Priority 0007911 30.03.00 GB

Filing date 28 March 2001

Wipo publication date 8 October 2001

Acceptance publication date 30 June 2005

International Classifications

C07K 016/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61P 037/00 Drugs for immunological or allergic disorders

A61P 029/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 001/04 Drugs for disorders of the alimentary tract or the digestive system

A61K 039/395 Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

30 June 2005 Application Accepted

  Published as AU-B-2001246516

27 October 2005 Standard Patent Sealed

21 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001246517

2001246514